Harmony Biosciences (HRMY)
(Delayed Data from NSDQ)
$27.28 USD
+0.52 (1.94%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $27.18 -0.10 (-0.37%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Harmony Biosciences Holdings, Inc. has a PEG ratio of 0.33 compared to the Medical - Biomedical and Genetics industry's PEG ratio of 1.82.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HRMY 27.28 +0.52(1.94%)
Will HRMY be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for HRMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HRMY
HRMY Stock Down as Fragile X Syndrome Study Fails to Meet Goal
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
HRMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates
Analysts Estimate Stoke Therapeutics, Inc. (STOK) to Report a Decline in Earnings: What to Look Out for
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Other News for HRMY
Death Cross appears for HRMY after 1.94% move
Is HRMY ready to make a move? NR7 shows up after dropping 0.59%
New 52 Week Low appears for HRMY after 2.32% move
NR7 appears for HRMY after 0.29% move
Lower Bollinger Band Walk appears for HRMY after 0.47% move